Title: Pioneering Sustainability: Pharma Impex Laboratories Leads the Way with 265 kW Solar Capacity
Pharma Impex Laboratories, a distinguished Pharma Manufacturing firm located in Baruipur, West Bengal, strides boldly into a sustainable future with the installation of a robust 265 kW solar system. This significant endeavor is made possible through a partnership with SolarLogix, a trusted TATA Power Solar Authorized EPC Channel Partner.
Solar Generation and Environmental Impact:
Each day, the solar infrastructure at Pharma Impex Laboratories generates a commendable 943.4 units of clean electricity, leading to substantial yearly savings of Rs. 2,926,898.5. Beyond the economic benefits, this initiative underscores the company’s dedication to environmental stewardship.
The environmental impact of Pharma Impex Laboratories’ solar initiative is profound. With a CO2 offset of 5496.683 metric tons annually, the company contributes significantly to reducing its carbon footprint. This offset is equivalent to the environmental benefit of nurturing 6452.962 acres of forest each year, emphasizing the tangible contribution towards mitigating climate change.
Moreover, the avoidance of coal burn amounts to 2726.0285 metric tons annually, equivalent to planting an impressive 90,963.529 trees. Additionally, the avoidance of 2,344,422.9615 liters of petrol consumption translates to covering an impressive 21,613,604.1295 kilometers, highlighting the far-reaching benefits of transitioning to renewable energy sources.
GI Sheet Roof Structure Installation:
The solar installation at Pharma Impex Laboratories features a GI sheet roof structure, ensuring optimal utilization of available space while seamlessly integrating with existing infrastructure. This innovative design not only maximizes energy generation but also exemplifies a harmonious blend of functionality and sustainability.
Financial Viability and Return on Investment:
Despite its significant environmental impact, the solar investment at Pharma Impex Laboratories also offers compelling financial returns. With a return on investment of 15.25% and a payback period of 6.56 years, the decision to embrace solar energy demonstrates the company’s long-term commitment to sustainability and financial prudence.
In conclusion, Pharma Impex Laboratories’ collaboration with SolarLogix sets a precedent for sustainable practices within the pharmaceutical manufacturing industry. By harnessing the power of the sun, the company not only secures energy independence but also demonstrates its dedication to environmental responsibility, paving the way for a brighter and more sustainable future.
